CGC — Canopy Growth Corporation stock price, charts and financials

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Canada

Latest market price

0.94

+0.02+2.57%

Overview Short InterestFilings

CGCQT39Canopy Growth Corporation·NASDAQ

Overview Short InterestFilings

0.94+2.57%

Loading chart...

Signal & projected range

Insider open-market saleHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

EBS+4.00%$7.02 TLRY+0.25%$3.94 KMDA+5.86%$8.67 EOLS+0.25%$8.01 EVO+2.45%$1.67 AQST-3.32%$4.66 IRWD+1.44%$4.23 COLL+0.86%$22.38

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	35.13%	Shs Outstand	422.15M	Perf Week	-4.57%

Market Cap	386.53M	Forward P/E	-	EPS next Y	-0.06	Insider Trans	-0.20%	Shs Float	415.29M	Perf Month	-8.44%

Enterprise Value	331.53M	PEG	-	EPS next Q	-0.02	Inst Own	-	Short Float	6.27%	Perf Quarter	-4.43%

Income	-189.00M	P/S	1.67	EPS this Y	85.27%	Inst Trans	-	Short Ratio	5.91	Perf Half Y	-14.43%

Sales	232.00M	P/B	0.80	EPS next Y	23.26%	ROA	-21.43%	Short Interest	26.04M	Perf YTD	-19.68%

Book/sh	1.15	P/C	1.61	EPS next 5Y	-	ROE	-29.85%	52W High	2.44 -61.53%	Perf Year	-34.13%

Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	-	ROIC	-15.31%	52W Low	0.87 8.55%	Perf 3Y	-94.58%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-6.50% -12.99%	Gross Margin	22.87%	Volatility	3.23% 3.35%	Perf 5Y	-99.42%

Dividend TTM	-	EV/Sales	1.43	EPS Y/Y TTM	87.42%	Oper. Margin	-46.89%	ATR (14)	0.03	Perf 10Y	-96.97%

Dividend Ex-Date	-	Quick Ratio	2.39	Sales Y/Y TTM	20.21%	Profit Margin	-73.95%	RSI (14)	35.02	Recom	2.93

Dividend Gr. 3/5Y	-	Current Ratio	3.04	EPS Q/Q	98.55%	SMA20	-7.23%	Beta	0.82	Target Price	11.02

Payout	0.00%	Debt/Eq	0.38	Sales Q/Q	13.46%	SMA50	-5.06%	Rel Volume	0.39	Prev Close	0.92

Employees	1,128	LT Debt/Eq	0.36	Earnings	Nov 06	SMA200	-15.05%	Avg Volume	3.36M	Price	0.94

IPO Date	Apr 07, 2014	Option/Short	No / No	EPS/Sales Surpr.	52.00% 35.98%	Net Debt/EBITDA	1.76	Volume	1,320,261	Change	2.57%

Analyst Ratings

Date	Action	Analyst	Rating
Nov-10-25	Upgrade	Benchmark	Sell → Hold
Nov-10-25	Upgrade	The Benchmark Company	Sell → Hold
Mar-21-22	Downgrade	Barclays	Equal Weight → Underweight
Jan-06-22	Reiterated	Alliance Global Partners	Hold
Dec-21-21	Downgrade	B of A Securities	Neutral → Underperform
Dec-19-21	Downgrade	Piper Sandler	Neutral → Underweight
Nov-23-21	Reiterated	Jefferies	Hold
Nov-07-21	Downgrade	Cowen & Co.	Outperform → Market Perform
Aug-11-21	Upgrade	Jefferies	Underperform → Hold
Jun-03-21	Reiterated	Desjardins

Latest News· Times ET

Today

Today02:50PM

Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Knowzacks.com

Sep-16-26

Sep-16-2606:01AM

Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stockzacks.com

Sep-14-26

Sep-14-2603:00PM

Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for Investorszacks.com

07:00AM

Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better?fool.com

03:30AM

Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadlinebusinesswire.com

Sep-11-26

Sep-11-2608:44AM

TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?Yahoo

Sep-09-26

Sep-09-2611:45PM

Canopy Growth (NASDAQ:CGC) vs. Clene (NASDAQ:CLNN) Financial Comparisondefenseworld.net

Sep-08-26

Sep-08-2609:29PM

Canopy Growth Corporation (NASDAQ:CGC) Receives Average Recommendation of “Hold” from Brokeragesdefenseworld.net

03:30AM

Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulationsbusinesswire.com

Sep-07-26

Sep-07-2607:40AM

Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why.Yahoo

03:20AM

Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted.fool.com

Sep-05-26

Sep-05-2603:15AM

Should You Buy Canopy Growth Stock on the Rebound?fool.com

Sep-02-26

Sep-02-2607:00AM

Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?fool.com

Sep-01-26

Sep-01-2606:00AM

3 Top Marijuana Stocks to Watch in September 2026marijuanastocks.com

Aug-28-26

Aug-28-2609:49AM

President And Founder Of Seabreeze Capital Partners LP Dougie Kass Posts On X "We have moved to super size $MSOS and individual cannabis stocks in the belief that a favorable rescheduling announcement will come shortly."Benzinga

Company

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2026 3/31/2026	FY 2025 3/31/2025	FY 2024 3/31/2024	FY 2023 3/31/2023	FY 2022 3/31/2022	FY 2021 3/31/2021	FY 2020 3/31/2020	FY 2019 3/31/2019
Total Revenue	232	206	193	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	174	156	136	—	—	—	—	—	—
Gross Profit	59	50	57	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	104	89	87	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	29	14	54	—	—	—	—	—	—
Operating Income	-74	-53	-84	—	—	—	—	—	—
Interest Expense	31	28	54	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-81	-110	-291	—	—	—	—	—	—
Net Income Before Taxes	-188	-190	-429	—	—	—	—	—	—
Income Taxes	-1	0	5	—	—	—	—	—	—
Consolidated Net Income	-189	-190	-430	—	—	—	—	—	—
Net Income From Continuing Operations	-189	-190	-434	—	—	—	—	—	—
Net Income	-189	-190	-430	—	—	—	—	—	—
EPS (Recurring)	-0.50	-0.64	-3.97	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.50	-0.64	-3.97	—	—	—	—	—	—
EPS (Diluted)	-0.50	-0.64	-3.97	—	—	—	—	—	—
EBITDA	-136	-136	-345	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	1.71	13.73	0.51	—	—	—	—	—	—
Gross Margin	25.43	24.27	29.53	—	—	—	—	—	—
Operating Margin	-31.90	-25.73	-43.52	—	—	—	—	—	—
Net Margin	-81.47	-92.23	-222.80	—	—	—	—	—	—
Shares Outstanding	422	2,980	108	—	—	—	—	—	—
Market Capitalization	396	2,829	98	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Thomas Carlton	See Remarks	Sep 17 '26	Sale	0.93	25,755	23,952	588,412	Sep 17
Gedeon Christelle	See Remarks	Aug 24 '26	Sale	1.47	13,344	19,616	692,162	Aug 25
Stewart Thomas Carlton	See Remarks	Aug 24 '26	Sale	1.47	2,231	3,280	614,167	Aug 25
BAYERN JOSEPH	Director	Jun 26 '26	Sale	0.92	3,197	2,953	145,127	Jun 29
Yanofsky Theresa	Director	Jun 26 '26	Sale	0.92	15,054	13,905	146,415	Jun 29
ATKINS M SHAN	Director	Jun 26 '26	Sale	0.92	3,197	2,953	146,517	Jun 29
Lazzarato David Angelo	Director	Jun 26 '26	Sale	0.92	22,674	20,944	211,859	Jun 29
Gedeon Christelle	See Remarks	Jun 17 '26	Sale	0.97	58,994	57,466	705,506	Jun 22
Mongeau Luc	Chief Executive Officer	Jun 17 '26	Sale	0.97	135,231	131,729	1,723,913	Jun 22
Stewart Thomas Carlton	See Remarks	Jun 17 '26	Sale	0.97	9,285	9,045	616,398	Jun 22
Yanofsky Theresa	Director	Mar 31 '26	Sale	0.93	10,373	9,647	53,145	Apr 02
ATKINS M SHAN	Director	Mar 31 '26	Sale	0.93	2,074	1,929	41,390	Apr 02
BAYERN JOSEPH	Director	Mar 31 '26	Sale	0.93	2,658	2,472	40,000	Apr 02
Lazzarato David Angelo	Director	Mar 31 '26	Sale	0.93	15,624	14,530	72,048	Apr 02
Mongeau Luc	Chief Executive Officer	Feb 11 '26	Sale	1.06	9,376	9,951	802,992	Feb 12

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.